<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">20869315</PMID>
        <DateCompleted>
            <Year>2011</Year>
            <Month>02</Month>
            <Day>01</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1474-5488</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>12</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2011</Year>
                        <Month>Jan</Month>
                    </PubDate>
                </JournalIssue>
                <Title>The Lancet. Oncology</Title>
                <ISOAbbreviation>Lancet Oncol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Drug interactions in childhood cancer.</ArticleTitle>
            <Pagination>
                <MedlinePgn>92-9</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/S1470-2045(10)70105-4</ELocationID>
            <Abstract>
                <AbstractText>Children with cancer are increasingly benefiting from new treatment strategies and advances in supportive care, as shown by improvements in both survival and quality-of-life. However, the continuous emergence of new cancer drugs and supportive-care drugs has increased the possibility of harmful drug interactions; health-care providers need to be very cautious when combining drugs. We discuss the most common interactions between chemotherapeutic drugs and supportive-care drugs-such as anticonvulsants, antiemetics, uric-acid-lowering compounds, acid suppressants, antimicrobials, and pain-management medications in paediatric patients. We also review the interactions between chemotherapy drugs and food and herbal supplements, and provide recommendations to avoid unwanted and potentially fatal interactions in children with cancer. Because of the constant release of new drugs, health-care providers need to check the most recent references before making recommendations about drug interactions.</AbstractText>
                <CopyrightInformation>Copyright Â© 2011 Elsevier Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Haidar</LastName>
                    <ForeName>Cyrine</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmaceutical Sciences, St Jude Children's Research Hospital, Memphis, TN, USA. cyrine.haidar@stjude.org</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jeha</LastName>
                    <ForeName>Sima</ForeName>
                    <Initials>S</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>P30 CA021765</GrantID>
                    <Acronym>CA</Acronym>
                    <Agency>NCI NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>CA21765</GrantID>
                    <Acronym>CA</Acronym>
                    <Agency>NCI NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2010</Year>
                <Month>09</Month>
                <Day>22</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Lancet Oncol</MedlineTA>
            <NlmUniqueID>100957246</NlmUniqueID>
            <ISSNLinking>1470-2045</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000863">Antacids</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000890">Anti-Infective Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000927">Anticonvulsants</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000932">Antiemetics</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000863" MajorTopicYN="N">Antacids</DescriptorName>
                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000890" MajorTopicYN="N">Anti-Infective Agents</DescriptorName>
                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000927" MajorTopicYN="N">Anticonvulsants</DescriptorName>
                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000932" MajorTopicYN="N">Antiemetics</DescriptorName>
                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName>
                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000529" MajorTopicYN="N">Complementary Therapies</DescriptorName>
                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004347" MajorTopicYN="Y">Drug Interactions</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018565" MajorTopicYN="N">Food-Drug Interactions</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2010</Year>
                <Month>9</Month>
                <Day>28</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2010</Year>
                <Month>9</Month>
                <Day>28</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2011</Year>
                <Month>2</Month>
                <Day>2</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">20869315</ArticleId>
            <ArticleId IdType="pii">S1470-2045(10)70105-4</ArticleId>
            <ArticleId IdType="doi">10.1016/S1470-2045(10)70105-4</ArticleId>
            <ArticleId IdType="pmc">PMC4865887</ArticleId>
            <ArticleId IdType="mid">NIHMS755141</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Biochem Pharmacol. 1977 Mar 1;26(5):355-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">849329</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Pharmacol Ther. 2006 Oct;80(4):331-45</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17015051</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 1983 Feb;147(2):363</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6681828</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Cancer. 1978 Aug;38(2):316-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">698048</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Clin Pharmacol. 2002 Oct;58(7):491-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12389073</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Pharmacol Ther. 2003 Jul;74(1):17-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12844131</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Pharmacol Ther. 2002 Apr;71(4):226-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11956505</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pediatr Hematol Oncol. 2005 Jul;27(7):389-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16012330</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Clin Pharmacol. 2007 Dec;64(6):772-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17662086</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 1994 Aug;12(8):1667-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8040679</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Chemother Pharmacol. 2007 Feb;59(3):407-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17051369</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Pharmacol Ther. 2005 Sep;78(3):260-77</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16153397</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Dermatol. 2006 Jun;154(6):1169-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16704650</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Pharmacol Ther. 1987 Apr;41(4):384-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3470165</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2006 Jun 20;24(18):2932-47</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16717289</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Pharmacol Ther. 2002 Sep;72(3):276-87</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12235448</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Ther. 2008 Aug;30(8):1385-407</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18803983</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Intern Med. 1992 Nov 15;117(10):877-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1416570</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Chemother Pharmacol. 2005 Oct;56(4):370-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15838656</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Invest. 1998 Feb 15;101(4):847-54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9466980</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pediatr Hematol Oncol. 2009 Apr;31(4):292-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19346885</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Crit Rev Oncol Hematol. 2005 Aug;55(2):117-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15890526</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Oncol Pharm Pract. 2007 Dec;13(4):237-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18045784</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Pharmacol Ther. 1995 Jul;58(1):15-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7628178</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 1999 Oct 15;286(5439):487-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10521338</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Leukemia. 2000 Apr;14(4):567-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10764140</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ther Drug Monit. 2002 Aug;24(4):570-2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12142645</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Pharmacol. 2008 Mar;48(3):365-78</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18156365</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pediatr Hematol Oncol. 2002 Feb;24(2):130-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11990699</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Leukemia. 2005 Jan;19(1):34-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15510203</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Pharmacother. 2000 Sep;34(9):1024-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10981249</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Acta Paediatr. 2001 Oct;90(10):1204-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11697438</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 1994 Nov;12(11):2390-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7964955</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2003 Apr 15;36(8):1089-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12684931</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochem Pharmacol. 1995 May 11;49(9):1255-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7763306</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Pharmacol Ther. 1999 Dec;66(6):589-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10613614</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2009 Sep 20;27(27):4599-604</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19687340</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Drugs. 2009;69(13):1853-78</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19719336</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Clin Pharmacol. 2009 Jan;67(1):44-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19076159</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>World J Gastroenterol. 2007 Dec 28;13(48):6608-111</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18161937</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Hematol Oncol. 1986;3(4):319-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3153245</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nephrol Dial Transplant. 1999 Jul;14(7):1698-703</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10435879</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Kidney Dis. 2005 May;45(5):804-17</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15861345</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Drug Metab Rev. 2002 Feb-May;34(1-2):47-54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11996011</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Natl Cancer Inst. 2002 Aug 21;94(16):1247-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12189228</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bone Marrow Transplant. 1999 Jul;24(1):1-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10435726</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Clin Pharmacol. 2009 Sep;68(3):370-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19740393</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 1996 Mar;14(3):935-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8622042</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2004 Jun 15;22(12):2489-503</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15197212</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Health Syst Pharm. 2008 Dec 1;65(23):2229-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19020190</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pediatr. 1990 Nov;117(5):823-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2231218</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 1972 Jun;32(6):1283-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">5030828</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bone Marrow Transplant. 2009 Sep;44(6):371-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19270729</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2003 Sep 18;349(12):1157-67</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">13679531</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Blood. 2004 Jan 1;103(1):67-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12969965</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2004 May 27;429(6990):464-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15164072</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2000 Jul 22;356(9226):285-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11071183</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Oncol. 2001 Feb;12(2):217-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11300327</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Pharmacol Ther. 1983 Dec;34(6):810-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6580097</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Clin Pharmacol. 1998 Jun;45(6):539-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9663808</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Pharmacother. 1992 Feb;26(2):234-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1554938</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Oncol. 2004 Aug;5(8):489-96</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15288238</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Transplant. 2000 Nov;4(4):313-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11079273</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Rheumatol. 1991 Apr;18(4):609-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2066953</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 1984 Jun;2(6):655-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6539365</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Clin Pharmacol. 1992;42(2):121-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1618240</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 1984 May;44(5):1913-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6713392</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pharmacogenomics. 2008 Sep;9(9):1267-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18781855</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Cancer. 1997 Jan;33(1):153-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9071915</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Pediatr Hematol Oncol. 1989 Winter;11(4):481-2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2618985</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>